Stem cell properties and the side population cells as a target for interferon-α in adult T-cell leukemia/lymphoma

Biochemical and Biophysical Research Communications

Volumn 364, Issue 4, 2007, Pages 808-814

  Kayo, Hiroyuki ^a   Yamazaki, Hiroto ^a   Nishida, Hiroko ^a   Dang, Nam H ^b   Morimoto, Chikao ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b NEVADA CANCER INSTITUTE   (United States)

Author keywords

Adult T cell leukemia lymphoma; Cancer stem cells; Interferon ; Side population

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; STAT1 PROTEIN; STAT5 PROTEIN;

ARTICLE; CANCER IMMUNOTHERAPY; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG TARGETING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION;

CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; INTERFERON-ALPHA; LEUKEMIA, T-CELL; NEOPLASM PROTEINS; STEM CELLS;

EID: 36048933772     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.070     Document Type: Article

References (22)

1. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
2. Huntly B.J.P., and Gilliland D.G. Leukemia stem cells and the evolution of cancer-stem-cell research. Nature Review 5 (2005) 311-321
3. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., and Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine 7 (2001) 1028-1034
4. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nature Reviews Cancer 2 (2002) 48-58
5. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., and Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 14228-14233
6. Kondo T., Setoguchi T., and Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 781-786
7. Chiba T., Kita K., Zheng Y.W., Yokosuka O., Saisho H., Iwama A., Nakauchi H., and Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44 (2006) 240-251
8. Wulf G.G., Wang R.Y., Kuehnle I., Weidner D., Marini F., Brenner M.K., Andreef M., and Goodell M.A. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 98 (2001) 1166-1173
9. - progenitor cells from patients with acute myeloid leukemia. Blood 97 (2001) 3882-3889
10. Platet N., Mayolb J.F., Bergera F., Herodin F., and Wiona D. Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Letters 581 (2007) 1435-1440
11. Cox C.V., Evely R.S., Oakhill A., Pamphilon D.H., Goulden N.J., and Blair A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 104 (2004) 2919-2925
12. Cox C.V., Martin H.M., Kearns P.R., Virgo P., Evely R.S., and Blair A. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood 109 (2007) 674-682
13. Matsui W., Huff C.A., Wang Q., Malehorn M.T., Barber J., Tanhehco Y., Smith B.D., Civin C.I., and Jones R.J. Characterization of clonogenic multiple myeloma cells. Blood 103 (2004) 2332-2336
14. Taylor G.P., and Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24 (2005) 6047-6057
15. Mahieux R., and Hermine O. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-α. Leukemia Lymphoma 46 (2005) 347-355
16. Yilmaz O.H., Kiel M.J., and Morrison S.J. SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity. Blood 107 (2006) 924-930
17. Blair A., Hogge D.E., Ailles L.E., Lansdorp P.M., and Sutherland H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89 (1997) 3104-3112
18. Maeda M. Human T lymphotropic virus type-I (HTLV-I) immortalizes human T cells in vitro. Human Cell 5 (1992) 70-78
19. Zhang M., Zhang Z., Gilman C.K., Janik J., and Waldmann T.A. Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody. Blood 105 (2005) 1231-1236
20. Matikainen S., Sareneva T., Ronni T., Lehtonen A., Koskinen P.J., and Julkunen I. Interferon-α activates multiple STAT proteins and upregulates proliferation-associated IL-2R, c-myc, and pim-1 genes in human T cells. Blood 93 (1999) 1980-1991
21. Mayer I.A., Verma A., Grumbach I.M., Uddin S., Lekmine F., Ravandi F., Majchrzak B., Fujita S., Fish E.N., and Platanias L.C. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-α in BCR-ABL-expressing cells. J. Bio. Chem. 276 (2001) 28570-28577
22. Yanase N., Hata K., Shimo K., Hayashida M., Evers B.M., and Mizuguchi J. Requirement of c-Jun NH2-terminal kinase activation in interferon-α-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells. Exp. Cell Res. 310 (2005) 10-21